Cost-effectiveness of accepted measures for intervention in coronary heart disease.
Kuntz
K M
KM
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Lee
T H
TH
D003327:Coronary Disease / Q000191:economics* / Q000517:prevention & control / Q000628:therapy*; D003362:Cost-Benefit Analysis; D006801:Humans; D009204:Myocardial Revascularization / Q000191:economics; D019057:Quality-Adjusted Life Years; D015912:Thrombolytic Therapy / Q000191:economics